A subscription to JoVE is required to view this content. Sign in or start your free trial.
Presented here is a protocol to use controlled hyperthermia, generated by magnetic resonance-guided high intensity focused ultrasound, to trigger drug release from temperature-sensitive liposomes in a rhabdomyosarcoma mouse model.
Magnetic resonance-guided high intensity focused ultrasound (MRgHIFU) is an established method for producing localized hyperthermia. Given the real-time imaging and acoustic energy modulation, this modality enables precise temperature control within a defined area. Many thermal applications are being explored with this noninvasive, nonionizing technology, such as hyperthermia generation, to release drugs from thermosensitive liposomal carriers. These drugs can include chemotherapies such as doxorubicin, for which targeted release is desired due to the dose-limiting systemic side effects, namely cardiotoxicity. Doxorubicin is a mainstay for treating a variety of malignant tumors and is commonly used in relapsed or recurrent rhabdomyosarcoma (RMS). RMS is the most common solid soft tissue extracranial tumor in children and young adults. Despite aggressive, multimodal therapy, RMS survival rates have remained the same for the past 30 years. To explore a solution for addressing this unmet need, an experimental protocol was developed to evaluate the release of thermosensitive liposomal doxorubicin (TLD) in an immunocompetent, syngeneic RMS mouse model using MRgHIFU as the source of hyperthermia for drug release.
Rhabdomyosarcoma (RMS) is a skeletal muscle tumor that most commonly occurs in children and young adults1. Localized disease is often treated with multimodal treatment, including chemotherapy, ionizing radiation, and surgery. The use of multi-drug chemotherapy regimens is more prevalent in pediatric patients, with improved outcomes compared to their adult counterparts2; however, despite ongoing research efforts, the 5-year survival rate remains at around 30% in the most aggressive form of the disease3,4. The chemotherapy standard of care is a multidrug regimen th....
Research was performed in compliance with the animal care committees with approved animal use protocols under a supervising veterinarian at The Centre for Phenogenomics (TCP) and University Health Network (UHN) Animal Resource Centre (ARC) animal research facilities. All procedures, excluding the MRgHIFU, involving the animals were done in a biological safety cabinet (BSC) to minimize animal exposure to external air or susceptible infection.
1. Mouse breeding
Using the MRgHIFU-generated hyperthermia protocol, the tumors in the hind limb were able to be consistently heated to the desired set temperature for the duration of the treatment (Figure 4 shows a representative treatment, 10 or 20 min, n = 65). To consider a treatment to be successful, the ROI had to be maintained above 39 °C for the entirety of the treatment, with <6 °C variation throughout the treatment and without heating of off-target tissue. Additionally, the core temper.......
The protocol developed herein was used to target hind limb tumors using MRgHIFU for mild HT treatment and release encapsulated drugs from liposomes in vivo. Several critical steps were encountered in this protocol during the pilot study, and optimizing these critical steps accounted for the improved treatment success over the pilot study. First is the complete removal of the hair on the area to be sonicated. Any gas trapping within the fur prevents the ultrasound beam from passing and blocks ultrasound passage i.......
We would like to acknowledge our sources of funding for this project and the personnel involved including: C17 Research Grant, Canada Graduate Scholarship, Ontario Student Opportunity Trust Fund, and James J. Hammond Fund.
....Name | Company | Catalog Number | Comments |
1.5mL Eppendorf tubes | Eppendorf | 22363204 | |
1kb plus DNA Ladder | Froggabio | DM015-R500 | |
2x HS-Red Taq (PCR mix) | Wisent | 801-200-MM | |
7 Tesla MRI BioSpec | Bruker | T184931 | 70/30 BioSpec, Bruker, Ettlingen, Germany |
C1000 Thermal cycler | Biorad | 1851148 | |
Clippers | Whal Peanut | 8655 | |
Compressed ultrasound gel | Aquaflex | HF54-004 | |
Convection heating device | 3M Bair Hugger | 70200791401 | |
Depiliatory cream | Nair | 61700222611 | Shopper's Drug Mart |
DMEM | Wisent | 219-065-LK | |
DNeasy extraction kit | Qiagen | 69504 | |
DPBS | Wisent | 311-420-CL | |
Drug injection system | Harvard Apparatus | PY2 70-2131 | PHD 22/2200 MRI compatible Syringe Pump |
Eye lubricant | Optixcare | 50-218-8442 | |
F10 Media | Wisent | 318-050-CL | |
FBS | Wisent | 081-105 | |
Froggarose | FroggaBio | A87 | |
Gel Molecular Imager | BioRad | GelDocXR | |
Glutamax | Wisent | 609-065-EL | |
Heat Lamp | Morganville Scientific | HL0100Â | Similar to this product |
Intravascular Polyethylene tubing (0.015" ID x 0.043" OD, 20G) | SAI infusion | PE-20-100 | |
Isoflurane | Sigma | 792632 | |
M25FV24C Cell line | Gladdy Lab | N/A | |
Microliter Syringe | Hamilton | 01-01-7648 | |
Molecular Imager Gel Doc XR | Biorad | 170-8170 | |
Mouse holder | The 3D printing material used was ABS-M30i, and it was printed on FDM Fortus 380mc machine | N/A | Dimensions: length = 43 mm, outer radius = 15 mm, inner width (where the mouse would sit) = 20.7 mm. |
MyRun Machine | Cosmo Bio Co Ltd | CBJ-IMR-001-EX | |
Nanodrop 8000 Spectrophotometer | Thermo Scientific | ND-8000-GL | |
p53 primers | Eurofins | N/A | Custom Primers |
PCR tubes | Diamed | SSI3131-06 | |
Penicillin/Streptomycin | Wisent | 450-200-EL | |
Proteus software | Pichardo lab | N/A | |
Respiratory monitoring system | SAII | Model 1030 | MR-compatible monitoring and gating system for small animals |
Small Bore HIFU device, LabFUS | Image Guided Therapy | N/A | LabFUS, Image Guided Therapy, Pessac, France Number of elements 8 frequency 2.5 MHz diameter 25 mm radius of curvature 20 mm Focal spot size 0.6 mm x 0.6 mm x 2.0 mm Motor: axes 2 Generator: Number of channels 8 Maximum electrical power/channel Wel 4 Maximum electrical power Wel 32 Bandwidth 0.5 - 5 MHz Control per channel: Freq., Phase and. amplitude Measurements per channel: Vrms, Irms, cos(theta) Duty Cycle at 100% power % 100% for 1 min. Transducer: Number of elements 8 frequency 2.5 MHz diameter 25 mm radius of curvature 20 mm Focal spot size 0.6 mm x 0.6 mm x 2.0 mm |
SYBR Safe | ThermoFisher Scientific | S33102 | |
TAE | Wisent | 811-540-FL | |
Tail vein catheter (27G 0.5" ) | Terumo Medical Corp | 15253 | |
Thermal probes | Rugged Monitoring | L201-08 | |
Trypan blue | ThermoFisher Scientific | 15250061 | |
Trypsin | Wisent | 325-052-EL | |
Ultrasound Gel | Aquasonic | PLI 01-08 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved